A ruling that invalidated three of Teva's headache treatment patents has been thrown out, sending a long-running case back to ...
The Hong Kong partner brings more than 20 years’ experience and specialises in trademark strategy, cross-border enforcement, ...
Cancer drug researcher hit with suit over mutation-targeting tools ...
Fresh hire, who will take up his new role in May, brings years of expertise in pharmaceuticals and artificial intelligence to ...
16 March 2026 Research from the International Trademark Association finds in-house counsel taking on more strategic work ...
A US district court has allowed key elements of the generic drugmaker’s case against a rival to move forward, while drawing ...
Europe’s latest patent fee increases are modest at the EPO but include a rare steep hike in the UK, forcing applicants to ...
10 April 2026 The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such ...
IP finance gap risks startup exodus, EUIPO warns ...
The panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners.
In light of Emotional Perception AI, the UKIPO has rewritten the rules for “mixed inventions". Matt Jefferies and Eric McNeil ...
The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results